Orthopediatrics Corp (KIDS) financials
Orthopediatrics revenue and earnings by year
Orthopediatrics's revenue was $236 million in the fiscal year to December 31, 2025, up 15.4% from the year before. Net income was -$39.6 million, -16.8% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 22.8% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 236 | 205 | 149 | 122 | 98 | 71 | 73 | 58 | 46 | 37 |
| Revenue growth | 15.4% | 37.6% | 21.6% | 24.7% | 37.9% | -2.0% | 26.0% | 26.2% | 22.3% | — |
| Gross profit | 173 | 149 | 111 | 91 | 73 | 55 | 55 | 43 | 34 | 26 |
| Gross margin | 73.1% | 72.6% | 74.8% | 74.1% | 74.9% | 77.4% | 75.3% | 74.2% | 75.5% | 70.7% |
| Operating income | -39 | -35 | -27 | -25 | -18 | -27 | -9 | -10 | -6 | -5 |
| Operating margin | -16.6% | -17.1% | -18.0% | -20.8% | -18.4% | -37.6% | -12.6% | -17.0% | -14.1% | -13.7% |
| Net income | -40 | -38 | -21 | 1 | -16 | -33 | -14 | -12 | -24 | -12 |
| Net margin | -16.8% | -18.5% | -14.1% | 1.0% | -16.6% | -46.3% | -18.9% | -20.9% | -51.6% | -33.4% |
| Diluted EPS | -$1.69 | -$1.64 | -$0.92 | $0.06 | -$0.84 | -$1.81 | -$0.94 | -$0.96 | — | — |
| Free cash flow | -16 | -41 | -44 | -32 | -21 | -29 | -30 | -21 | -12 | -5 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open KIDS in Markets.
How Orthopediatrics makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Trauma & Deformity | $52.6M | 72.4% |
| Spine | $19.2M | 26.4% |
| Sports Medicine & Other | $866K | 1.2% |
See also: KIDS returns
No forecast, no recommendation. This page describes Orthopediatrics Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.